Reports for BAUSCH HEALTH, CANADA INC.
Company Name
BAUSCH HEALTH, CANADA INC.
Totals |
||
Shortage reports |
348 |
|
| Actual shortage: | 10 (3%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 34 (10%) | |
| Resolved: | 303 (87%) | |
Discontinuation Reports |
13 |
|
| To be discontinued: | 1 (8%) | |
| Discontinued: | 12 (92%) | |
| Reversed: | 0 (0%) | |
Late reports |
96 (27%) |
|
Overdue reports |
1 (8%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ALTACE HCT | 12.5MG 5MG | TABLET | Resolved | 2020-02-14 | 2020-05-13 | 106255 |
| TIAZAC XC | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-10-19 | 2018-11-09 | 64999 |
| MANERIX | 150MG | TABLET | Resolved | 2018-04-06 | 2018-04-27 | 45133 |
| MANERIX | 150MG | TABLET | Resolved | 2019-11-13 | 2020-02-24 | 98652 |
| MANERIX | 150MG | TABLET | Resolved | 2020-05-28 | 2020-06-16 | 116054 |
| MANERIX | 150MG | TABLET | Resolved | 2020-10-21 | 2020-11-25 | 126836 |
| MANERIX | 150MG | TABLET | Resolved | 2021-02-17 | 2021-04-01 | 134275 |
| MANERIX | 150MG | TABLET | Resolved | 2021-07-16 | 2021-08-26 | 142656 |
| MANERIX | 150MG | TABLET | Resolved | 2022-12-21 | 2023-01-04 | 179114 |
| ROFACT | 150MG | CAPSULE | Resolved | 2017-03-17 | 2017-06-16 | 3290 |
| ROFACT | 150MG | CAPSULE | Resolved | 2017-05-26 | 2017-06-16 | 11360 |
| ROFACT | 150MG | CAPSULE | Resolved | 2019-09-06 | 2020-03-18 | 93236 |
| ROFACT | 150MG | CAPSULE | Avoided shortage | 2020-04-09 | 2020-04-23 | 111785 |
| ROFACT | 150MG | CAPSULE | Resolved | 2020-06-03 | 2020-07-27 | 116496 |
| ROFACT | 150MG | CAPSULE | Resolved | 2022-12-07 | 2023-02-24 | 177254 |
| ROFACT | 150MG | CAPSULE | Avoided shortage | 2023-04-28 | 2023-05-31 | 191061 |
| CARBOLITH | 150MG | CAPSULE | Resolved | 2020-04-01 | 2020-05-01 | 110364 |
| WELLBUTRIN SR | 150MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2019-05-29 | 2019-06-07 | 85235 |
| ZYBAN | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-23 | 2019-03-05 | 73394 |
| WELLBUTRIN XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-09-10 | 2018-12-21 | 61167 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VITAMIN A ACID | 0.01% | GEL | To be discontinued | 2024-01-30 | 2024-01-30 | 217835 |
| VITAMIN A ACID | 0.025% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217848 |
| VITAMIN A ACID | 0.05% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217843 |
| LIDEX | 0.05% | CREAM | Discontinued | 2023-12-08 | 2023-12-08 | 212804 |
| AIROMIR | 100MCG | METERED-DOSE AEROSOL | Discontinued | 2023-11-29 | 2023-11-29 | 211859 |
| ALTACE HCT | 12.5MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214024 |
| ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |
| DELATESTRYL | 200MG | SOLUTION | Discontinued | 2024-03-11 | 2024-04-26 | 221772 |
| ALTACE HCT | 25MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214027 |
| ALTACE HCT | 25MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214017 |
| LODALIS | 3.75G | POWDER FOR SUSPENSION | Discontinued | 2023-12-08 | 2024-02-20 | 212799 |
| THEOLAIR | 80MG | SOLUTION | Discontinued | 2021-04-26 | 2021-04-27 | 138081 |
Showing 1 to 13 of 13